bioMérieux has created a new Fungal Susceptibility Card for susceptibility testing of Candida species and Cryptococcus neoformans. The VITEK 2 ASTYS07 card includes a sixth antifungal agent, ...
The FDA clearance of COPAN's Colibrí™ for MALDI and now Vitek 2 will save time and labor by automating crucial steps in diagnostic microbiology. When used with COPAN's advanced AI software, the ...
MARCY L'ÉTOILE, France, March 18, 2025 /PRNewswire/ --bioMérieux, a world leader in the field of in vitro diagnostics, announces the U.S. Food and Drug Administration (FDA) 510(k) clearance for VITEK ...
DENVER — Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry shortens the time it takes to identify the agent responsible for a bloodstream infection and can have ...
In December 2021, COPAN announced the FDA 510 (k) clearance of Colibrí™ for use with MALDI-TOF MS analyzers. This same instrument has now received its second FDA 510 (k) clearance for the preparation ...